Dieudonné Buh Kum, PhD, MBA

Dieudonné Buh Kum, PhD, MBA has a diverse work experience in the field of scientific research and project management. Dieudonné Buh currently works as a Scientist II at Aligos Therapeutics since December 2019, where they previously held the role of Scientist I. Prior to this, they served as a Project Manager at NovAliX from April 2019 to November 2019. Before joining NovAliX, they worked as a PhD researcher and later as a Research Associate at KU Leuven from June 2014 to March 2019. In addition, they briefly served as a Reseacher at The University of Texas Medical Branch at Galveston Texas from June 2016 to November 2016. Dieudonné Buh'searlier work experience includes working as a Medical Laboratory Scientist at St. Padre Pio Hospital from August 2009 to August 2012.

Dieudonné Buh Kum, PhD, MBA has a diverse education history. Dieudonné Buh started their academic journey in 2004 at the University of Buea, where they pursued a Bachelor of Science in Medical Laboratory Sciences (BMLS), which they completed in 2008.

After working in the field for a few years, Dieudonné decided to further their education and specialize in Biomedical Sciences, Immunology, and Microbiology. From 2015 to 2019, they attended KU Leuven, where they earned their Doctor of Philosophy (PhD) degree. During this time, they conducted research in the field of Immunology and Microbiology, focusing on biomedical sciences.

Prior to pursuing their PhD, Dieudonné completed a Master of Science (MSc) degree at KU Leuven from 2012 to 2014. Dieudonné Buh'smaster's program centered around Biophysics, Biochemistry, and Biotechnology.

To enhance their knowledge and skills in business administration, Dieudonné pursued a Master of Business Administration (MBA) degree from UNIR - La Universidad en Internet, completing it in 2021. This program allowed him to gain expertise in Business Administration and Management, covering various aspects of the field.

Additionally, Dieudonné holds a certification as an International Technologist in Molecular Biology (MB) from the American Society for Clinical Pathology (ASCP).